| Recruiting | Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting Nausea and Vomiting Chemotherapy-Induced, Nausea Post Chemotherapy | Phase 2 | 2025-07-07 |
| Terminated | A Clinical Trial to Assess Safety and Pharmacokinetics of Fosnetupitant 235 mg and Metabolites in Healthy Volu Healthy Volunteers | Phase 1 | 2023-06-17 |
| Withdrawn | Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade G Advanced Solid Tumor, CNS Tumor, Recurrent WHO Grade II Glioma | Phase 1 / Phase 2 | 2021-10-01 |
| Completed | Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk) Chemotherapy-induced Nausea and Vomiting | Phase 4 | 2021-02-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weigh Cachexia; Cancer, Non Small Cell Lung Cancer | Phase 3 | 2019-05-06 |
| Completed | A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weigh Cachexia; Cancer, Non Small Cell Lung Cancer | Phase 3 | 2019-03-05 |
| Completed | A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Co Chemotherapy-induced Nausea and Vomiting | Phase 3 | 2018-03-16 |
| Completed | A Study In Healthy Male Volunteers Designed To Investigate How A Radiolabelled Medicine Is Broken Down And Rem Healthy Subjects | Phase 1 | 2018-02-08 |
| Completed | PK/PD Study of Netupitant and Palonosetron in Pediatric Patients for Prevention of Chemotherapy-induced Nausea Chemotherapy-induced Nausea and Vomiting (CINV) | Phase 2 | 2017-08-31 |
| Terminated | Effects of Aqualief® in Patients With Xerostomia as Consequence of Radiotherapy for Head and Neck Cancer Xerostomia, Asialia, Hyposalivation | N/A | 2017-07-31 |
| Terminated | An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leuke Acute Myeloid Leukemia | Phase 3 | 2017-06-23 |
| Completed | Monocenter, Open Label Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Xonrid® Radiodermatitis, Quality of Life | N/A | 2017-06-15 |
| Terminated | A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndrome Myelodysplastic Syndromes | Phase 2 | 2017-06-01 |
| Withdrawn | Evaluation of the Effects of a Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patient Cancer Patients With Cachexia | N/A | 2016-10-01 |
| Completed | A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vom Chemotherapy-Induced Nausea and Vomiting | Phase 3 | 2015-11-01 |
| Completed | An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Pr Chemotherapy-Induced Nausea and Vomiting | Phase 3 | 2015-10-01 |
| Terminated | Effects of Somnage® in the Management on Sleep and Mood in Cancer Patients Breast Cancer, Lung Cancer, Colon Cancer | N/A | 2015-10-01 |
| Completed | Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of E Drug and/or Toxin-induced Diarrhea | Phase 2 | 2015-01-01 |
| Completed | Evaluate the Effects of Itraconazole and Ciprofloxacin on Single-Dose PK of Pracinostat in Healthy Nonsmoking Healthy Volunteers, Non-smokers | Phase 1 | 2014-05-01 |
| Completed | Study to Evaluate the Food Effect of Single-dose Bioavailability of Pracinostat in Healthy Adult Subjects Healthy Volunteers, Moderate to Heavy Smokers, Non-smokers | EARLY_Phase 1 | 2014-02-01 |
| Completed | Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myelo Acute Myeloid Leukemia | Phase 2 | 2013-12-24 |
| Completed | Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond t Myelodysplastic Syndrome, MDS | Phase 2 | 2013-12-01 |
| Completed | Efficacy Study of Ginger (Zingiber Officinale) Extract "Ginpax" to Manage Nausea in Cancer Patients Receiving Cancer, Nausea, Vomiting | N/A | 2013-06-01 |
| Completed | Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome Myelodysplastic Syndrome | Phase 2 | 2013-06-01 |
| Completed | Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea | Phase 2 | 2012-02-01 |
| Completed | Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in P Chemotherapy-Induced Nausea and Vomiting | Phase 3 | 2011-09-01 |
| Completed | An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting Chemotherapy-Induced Nausea and Vomiting | Phase 3 | 2011-07-01 |
| Completed | A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting Chemotherapy-Induced Nausea and Vomiting | Phase 3 | 2011-07-01 |
| Completed | Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients Postoperative Nausea and Vomiting | Phase 3 | 2011-06-01 |
| Completed | An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting Chemotherapy-Induced Nausea and Vomiting | Phase 3 | 2011-04-01 |
| Completed | Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients Postoperative Nausea and Vomiting | Phase 3 | 2008-08-01 |
| Terminated | XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors Biliary Tract Cancer | Phase 3 | 2004-09-01 |